Please use this identifier to cite or link to this item:
Title: Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study.
See erratum: Correction to: Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study. Handle: 10137/11757. Published 3 May 2021
Authors: Oliver J
Thielemans E
McMinn A
Baker C
Britton PN
Clark JE
Marshall HS
Blyth CC
Francis JR
Buttery J
Steer AC
Crawford NW
Citation: BMC public health 2019-12-30; 19(1): 1750
Abstract: Invasive group A Streptococcus (iGAS) disease is serious and sometimes life-threatening. The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network collects voluntary notifications from seven major Australian paediatric hospitals on patients with certain conditions, including iGAS disease. Our aims were to: 1) Describe the epidemiological distribution of paediatric iGAS disease in Australia and correlate this with influenza notifications, 2) Identify GAS strains commonly associated with invasive disease in children. IGAS and influenza notification data were obtained (from the PAEDS Network and the Australian Institute of Health and Welfare, respectively, for the period 1 July 2016 to 30 June 2018). Included iGAS patients had GAS isolated from a normally sterile body site. Data were described according to selected clinical and demographic characteristics, including by age group and Australian State, with proportions and minimum incidence rates estimated. A total of 181 patients were identified, with most (115, 63.5%) <5 years old. The mean annual minimum incidence rate was 1.6 (95% confidence interval: 1.1-2.3) per 100,000 children across the study period. An epidemiological correlation with the seasonal burden of influenza was noted. Contact prophylaxis was not consistently offered. Of 96 patients with emm-typing results available, 72.9% showed emm-1, -4 or - 12. Robust surveillance systems and cohesive patient management guidelines are needed. Making iGAS disease nationally notifiable would help facilitate this. Influenza vaccination may contribute to reducing seasonal increases in iGAS incidence. The burden of disease emphasises the need for ongoing progress in GAS vaccine development.
Click to open PubMed article:
Journal title: BMC public health
Publication Date: 2019-12-30
Type: Journal Article
DOI: 10.1186/s12889-019-8085-2
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing